Fifty years of outstanding neuroscience research studies have revealed many secrets of how drugs of abuse affect and change ...

The market for abuse-deterrent opioids is still developing, but it's estimated that replacing extended-release opioids with abuse-deterrent formulations could lead to significant cost savings and a ...

FN Media Group News Commentary - The market for abuse-deterrent opioids is still developing, but it's estimated that replacing extended-release opioids with abuse-deterrent formulations could lead to ...

A novel strategy involving blocking peripheral opioid receptors may reverse opioid overdose while avoiding withdrawal and ...

RLS disrupts sleep and daily life—but evidence-based treatments like iron, dopamine drugs, and lifestyle therapies offer real ...

Opioid Withdrawal Syndrome (OWS) is a major public health concern caused by the sudden reduction or cessation of opioids in ...

Opioid addiction led to most of the 17 overdose deaths reported in Cyprus in 2023, according to according to the national findings presented by the Cypriot National Addictions Authority (NAAC). The ...

A grassroots community coalition that advocates substance use disorder solutions celebrates 10 years at an event in ...

Dihydroergotamine (DHE) is an older drug used for migraine relief. Learn about new formulations and find out if you're a good candidate for this powerful treatment.

Background Intravenous iron therapy with ferric derisomaltose (FDI) has been shown to improve outcomes in patients with heart failure with reduced ejection fraction (HFrEF) and iron deficiency.

Delivered as a once-daily 30 mg/mL IV bolus injection over 15 seconds, Xifyrm can be used alone or alongside non-NSAID ...

For decades, people suffering from chronic restless leg syndrome have been treated with drugs that cause debilitating side ...